Correlation Between CV Sciences and Nexien Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CV Sciences and Nexien Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CV Sciences and Nexien Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CV Sciences and Nexien Biopharma, you can compare the effects of market volatilities on CV Sciences and Nexien Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CV Sciences with a short position of Nexien Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CV Sciences and Nexien Biopharma.

Diversification Opportunities for CV Sciences and Nexien Biopharma

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between CVSI and Nexien is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding CV Sciences and Nexien Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexien Biopharma and CV Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CV Sciences are associated (or correlated) with Nexien Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexien Biopharma has no effect on the direction of CV Sciences i.e., CV Sciences and Nexien Biopharma go up and down completely randomly.

Pair Corralation between CV Sciences and Nexien Biopharma

Given the investment horizon of 90 days CV Sciences is expected to generate 0.29 times more return on investment than Nexien Biopharma. However, CV Sciences is 3.49 times less risky than Nexien Biopharma. It trades about 0.04 of its potential returns per unit of risk. Nexien Biopharma is currently generating about -0.07 per unit of risk. If you would invest  4.00  in CV Sciences on September 1, 2024 and sell it today you would earn a total of  0.00  from holding CV Sciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CV Sciences  vs.  Nexien Biopharma

 Performance 
       Timeline  
CV Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CV Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, CV Sciences is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
Nexien Biopharma 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nexien Biopharma are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady technical and fundamental indicators, Nexien Biopharma displayed solid returns over the last few months and may actually be approaching a breakup point.

CV Sciences and Nexien Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CV Sciences and Nexien Biopharma

The main advantage of trading using opposite CV Sciences and Nexien Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CV Sciences position performs unexpectedly, Nexien Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexien Biopharma will offset losses from the drop in Nexien Biopharma's long position.
The idea behind CV Sciences and Nexien Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency